Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer

Fig. 2

Protein expression of SMARCAs obtained from the Human Protein Atlas (HPA) online database (scale bar, 200 μm). Staining was divided into not detected, low, medium and high based on the intensity of staining. A SMARCA1 protein was not detected in normal tissues and pancreatic cancer tissues; B, E, H SMARCA2/5 and SMARCAL1 protein were expressed medium or low in normal tissues, while high or medium expression were observed in pancreatic tissues; C, F SMARCA3 and HELLS protein were not observed in normal pancreatic tissues, whereas low and medium expression were detected in pancreatic cancer tissues, respectively; D SMARCA4 protein was expressed high both in normal tissues and pancreatic cancer tissues; G SMARCAD1 protein was lower in pancreatic cancer tissues compared to normal tissues

Back to article page